Abstract
From drug discovery and development to regulatory approval and marketing, the acceptable stability of the drug substance and drug product is one of the basic quality requirements. The overall stability of a drug product is related not only to the intrinsic chemical stability of the drug molecule, but also the physical form, manufacturing process, interactions among formulation components, package, and storage condition. In this paper, the major physical stability attributes of pharmaceuticals are discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adesunloye TA, Stach PE (1998) Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules. Drug Dev Ind Pharm 24:493–500
Almeida IF, Bahia MF (2006) Evaluation of the physical stability of two oleogels. Int J Pharm 327:73–77
Davis RE, Lorimer KA, Wilkowski MA, Rivers JH (2004) Studies of phase relationships in cocrystal systems. ACA Trans 39:41–61
Digenis GA, Gold TB, Shah VP (1994) Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci 83:915–921
Guo Y (2008) Impact of solid-state characteristics to the physical stability of drug substance and drug product in handbook of stability testing in pharmaceutical development (Kim Huynh-Ba ed.), Springer, New York, NY
Hlinak AJ, Kuriyan K, Morris KR, Reklaitis GV, Basu PK (2006) Understanding critical material properties for solid dosage form design. J Pharm Innovation 1(1):12–17
ICH guidance Q1A (R2) (2003) Stability testing of new drug substances and products http://ww.w.ich.org
Morris KR, Griesser UJ, Eckhardt CJ, Stowell JG (2001) Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Deliv Rev 48:91–114
Nakamura K, Yokohama S, Sonobe T (2002) Failure of stability prediction for minodronic acid injectable by accelerated stability testing. Int J Pharm 241:65–71
Rubino JT, Chen LL, Walker JT, Segretario J, Everlof JG, Hussain MA (1999) Photoinduced particulate matter in a parenteral formulation for bisnafide, an experimental antitumor agent. Pharm Dev Tech 4:439–447
Tong WQ, Clark J, Franklin ML, Jozwiakowski JP, Lemmo JB, Sisco JM, Whight SR (1996) Identification and characterization of the sulfate precipitate in GI147211C IV formulation. PDA J Pharm Sci and Tech 5:326–329
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Guo, Y. (2010). An Overview of Physical Stability of Pharmaceuticals. In: Huynh-Ba, K. (eds) Pharmaceutical Stability Testing to Support Global Markets. Biotechnology: Pharmaceutical Aspects, vol XII. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0889-6_19
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0889-6_19
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0888-9
Online ISBN: 978-1-4419-0889-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)
